Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Southwell David P
Relationship:   Chief Executive Office...
City:   Concord
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   337,703    

Indirect Shares

   1,650      
Direct Value   $3,259,103    

Indirect Value

   $51,447      
Total Shares   339,353      
Total Value   $3,310,550      


First Eagle Alternative Capital BDC, Inc $174,790 PTC Therapeutics, Inc. $400,663 Rocket Pharmaceuticals $2,683,650 Tscan Therapeutics, Inc. $0 First Eagle Alternative Capital BDC, Inc $174,790 PTC Therapeutics, Inc. $400,663 Rocket Pharmaceuticals $2,683,650 Tscan Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   -2.0   
     Percentage Gain/Loss :
     0.0%
 -6.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Human Genome Sciences Inc HGSI Chief Financial Officer 2012-07-30 0 2009-03-13 0    Premium*  
            First Eagle Alternative Capital ... FCRD Director 2010-12-06 38,500 2010-11-16 0    Premium*  
            PTC Therapeutics, Inc. PTCT 2024-05-08 12,850 2024-05-08 1,650    Premium*  
            Rocket Pharmaceuticals RCKT 2024-04-15 114,784 2017-01-06 0    Premium*  
            Tscan Therapeutics, Inc. TCRX Chief Executive Office... 2022-05-18 171,569 2021-09-08 0    Premium*  
* Premium Members only  

Records found :    45         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HGSI Human Genome Sciences Inc Director   –       •      –    2009-03-13 4 B $0.72 $52,341 D/D 73,000 73,000 2.39 -
HGSI Human Genome Sciences Inc David Southwell   •       –      –    2010-04-12 4 A $32.86 $3,187 D/D 97 73,097 0 -
HGSI Human Genome Sciences Inc David Southwell   •       –      –    2010-06-01 4 OE $2.09 $101,731 D/D 17,653 90,750 0 -
HGSI Human Genome Sciences Inc David Southwell   •       –      –    2010-07-12 4 A $32.86 $2,793 D/D 85 90,835 0 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-16 4 B $12.84 $110,706 D/D 8,622 8,622 2.39 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-17 4 B $12.80 $70,324 D/D 5,478 14,100 2.39 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-18 4 B $12.82 $146,365 D/D 11,400 25,500 2.39 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-19 4 B $12.83 $6,406 D/D 499 25,999 2.39 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-22 4 S $12.82 $1,296 D/D (101) 26,100 0 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-22 4/A B $12.82 $1,296 D/D 101 26,100 2.31 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-23 4 S $12.83 $1,283 D/D (100) 26,200 0 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-23 4/A B $12.83 $1,283 D/D 100 26,200 2.31 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-24 4 B $12.84 $2,568 D/D 200 26,400 2.31 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-12-06 4 B $12.97 $157,277 D/D 12,100 38,500 2.39 -
HGSI Human Genome Sciences Inc Chief Financial Officer   •       •      –    2012-07-30 4 D $14.25 $1,294,399 D/D (90,835) 0 0 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2014-03-21 4 AS $30.54 $71,666 D/D (2,317) 10,921 0 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2015-03-23 4 AS $68.99 $159,957 D/D (2,317) 8,604 0 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2015-07-06 4 OE $10.85 $162,750 D/D 15,000 23,604 0 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2015-07-06 4 AS $47.50 $1,121,694 D/D (23,604) 0 0 -
RCKT Rocket Pharmaceuticals President and CEO   •       •      –    2017-01-06 4 B $1.75 $105,000 D/D 60,000 62,765 2.81 -
RCKT Rocket Pharmaceuticals Director   –       •      –    2018-04-02 4 OE $0.00 $0 D/D 21,875 38,535 0 -
RCKT Rocket Pharmaceuticals   •       •      –    2018-11-28 4 OE $0.00 $0 D/D 153,125 191,660 0 -
RCKT Rocket Pharmaceuticals   •       •      –    2018-12-06 4 S $15.15 $800,056 D/D (52,809) 138,851 0 -
RCKT Rocket Pharmaceuticals   •       •      –    2018-12-07 4 S $14.91 $73,402 D/D (4,923) 133,928 0 -
RCKT Rocket Pharmaceuticals   •       •      –    2018-12-13 4 S $15.19 $588,886 D/D (38,768) 95,160 0 -
  45  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us